Submit Your Prostate Cancer Research
Join leading pathophysiology researchers advancing our understanding of prostate cancer mechanisms, biomarkers, and molecular pathways through rigorous peer review and open access publication.
Two Convenient Submission Methods
We offer two streamlined online submission pathways designed to accommodate your research workflow. Choose the method that best suits your needs—both ensure your prostate cancer pathophysiology research receives expert evaluation from specialists in molecular mechanisms, disease progression, and biomarker discovery.
ManuscriptZone Portal
Our comprehensive manuscript management system designed for researchers who value complete control and real-time tracking throughout the peer review process.
- Auto-save functionality protects your work
- Real-time submission status tracking
- Direct access to reviewer comments and editor decisions
- Guided workflow with validation checks
- Secure document management and version control
- Mobile-responsive interface for submissions on any device
Best for: Original research articles, systematic reviews, and manuscripts requiring multiple revisions or collaborative author input.
Submit via ManuscriptZoneQuick Submission Form
A streamlined submission pathway for researchers who prefer a simplified process without account creation, perfect for straightforward manuscripts ready for immediate submission.
- No account registration required
- Single-page submission interface
- Fast upload for complete manuscripts
- Immediate confirmation upon submission
- Ideal for time-sensitive research communications
Best for: Short communications, case reports, letters to the editor, and manuscripts from authors preferring a simplified submission experience.
Use Quick Submission FormArticle Types We Publish
The International Journal of Prostate Cancer welcomes diverse manuscript types that advance our understanding of prostate cancer pathophysiology. Our expert reviewers—specialists in molecular biology, cancer biology, and disease mechanisms—evaluate submissions across multiple research formats.
Original Research Articles
Comprehensive studies investigating molecular mechanisms of prostate cancer development, progression, and metastasis. Include gene expression analyses, proteomics, cellular pathway studies, and mechanistic investigations.
Biomarker Discovery Studies
Research identifying and validating novel diagnostic, prognostic, or predictive biomarkers for prostate cancer. Include molecular signatures, protein markers, genetic variants, and circulating biomarkers.
Disease Model Development
Studies establishing or characterizing in vitro, in vivo, or computational models of prostate cancer. Include cell line development, xenograft models, organoid systems, and mathematical modeling approaches.
Systematic Reviews & Meta-Analyses
Comprehensive syntheses of existing literature on prostate cancer pathophysiology, molecular mechanisms, or biomarker performance. Must follow PRISMA guidelines for systematic reviews.
Methods & Protocols
Detailed descriptions of novel experimental techniques, assay development, or analytical methods for studying prostate cancer biology. Include validation data and reproducibility assessments.
Short Communications
Concise reports of preliminary findings, novel observations, or significant negative results in prostate cancer research. Ideal for time-sensitive discoveries requiring rapid dissemination.
Case Reports
Detailed documentation of unusual presentations, rare molecular profiles, or unexpected disease mechanisms in prostate cancer. Must include pathophysiological insights and mechanistic discussion.
Review Articles
Comprehensive, critical analyses of current understanding in specific areas of prostate cancer pathophysiology. Should provide expert synthesis and identify knowledge gaps for future research.
Note: All submissions undergo rigorous evaluation by peer reviewers with expertise in prostate cancer biology, molecular pathology, and disease mechanisms. We prioritize manuscripts that advance mechanistic understanding and contribute novel insights to the field.
Pre-Submission Checklist
Ensure your manuscript meets our submission requirements before uploading. Complete manuscripts that adhere to our guidelines receive faster editorial screening and proceed more quickly to peer review.
- Manuscript File: Prepared in Microsoft Word (.docx) or LaTeX format with all sections complete (title, abstract, introduction, methods, results, discussion, conclusions, references)
- Figures and Tables: High-resolution figures (minimum 300 DPI) in TIFF, EPS, or PNG format; tables formatted in Word or Excel with clear legends and captions
- Ethics Documentation: IRB/Ethics committee approval obtained for human studies; IACUC approval for animal studies; compliance with ARRIVE guidelines for animal research
- Author Information: Complete names, affiliations, ORCID IDs, and email addresses for all authors; corresponding author clearly designated
- Competing Interests: Declaration of financial relationships, conflicts of interest, or competing interests for all authors
- Funding Statement: Acknowledgment of all funding sources with grant numbers; statement if no funding was received
- Data Availability: Statement describing how readers can access underlying data; repository links for genomic, proteomic, or other large datasets
- Author Contributions: Clear description of each author's contribution using CRediT taxonomy (Conceptualization, Methodology, Investigation, Writing, etc.)
- References: Formatted according to journal style; all citations verified and accessible; DOIs included where available
Peer Review Timeline
We are committed to transparent, efficient peer review that respects your time while maintaining rigorous quality standards. Our editorial team and expert reviewers work collaboratively to provide constructive feedback that strengthens your research.
Submission Received
Your manuscript is registered in our system and assigned a unique tracking number. You receive immediate confirmation with submission details.
Day 0Editorial Screening
The Editor-in-Chief or Associate Editor reviews your manuscript for scope, quality, and adherence to submission guidelines. Manuscripts are screened for plagiarism using iThenticate (similarity index must be below 30%).
Days 1-3Reviewer Assignment
An editor with expertise in your research area assigns 2-3 peer reviewers who are specialists in prostate cancer pathophysiology, molecular mechanisms, or related disciplines.
Days 4-7Peer Review
Expert reviewers evaluate your manuscript for scientific rigor, methodological soundness, novelty, and significance to the field. Reviewers provide detailed feedback and recommendations.
Days 8-21Editorial Decision
The handling editor synthesizes reviewer comments and makes a decision: Accept, Minor Revisions, Major Revisions, or Reject. You receive the decision with detailed reviewer feedback.
Days 22-28Revision Submission
If revisions are requested, you submit your revised manuscript with a detailed response to reviewer comments. We recommend submitting revisions within 30 days to maintain review momentum.
Author timelineRe-review (if needed)
Revised manuscripts are returned to the original reviewers for evaluation of changes. This process is typically faster than initial review as reviewers focus on specific revisions.
Days 29-42Final Decision & Acceptance
Upon acceptance, your manuscript proceeds to production. You receive a formal acceptance letter and information about publication timeline and article processing charges.
Day 43-50Production & Publication
Your manuscript undergoes copyediting, formatting, and XML conversion. You review and approve proofs before final publication. Articles are published online immediately upon completion.
Days 51-60Average Time to Publication: Approximately 60 days from initial submission to online publication for manuscripts accepted without major revisions. We prioritize timely decisions while maintaining rigorous peer review standards.
Why Researchers Choose IJPC
The International Journal of Prostate Cancer provides a trusted platform for disseminating high-quality research in prostate cancer pathophysiology. Our commitment to scientific rigor, transparency, and open access ensures your work reaches the global research community.
Comprehensive Indexing
Your research gains worldwide visibility through indexing in Google Scholar, connecting it with the global scientific community.
Expert Peer Review
Manuscripts evaluated by specialists in prostate cancer biology, molecular pathology, and disease mechanisms who provide constructive, rigorous feedback.
Fast Decisions
Average time to first decision: 21 days. We respect your time while maintaining thorough peer review standards.
Open Access Impact
Immediate, unrestricted access to your research worldwide. No paywalls limiting readership or citations of your work.
Ethical Publishing
COPE (Committee on Publication Ethics) member committed to highest standards of research integrity and publication ethics.
APC Waivers Available
Financial support available for eligible authors from low- and middle-income countries. Quality research should not be limited by funding.
Submission Guidelines Summary
Manuscript Preparation
Manuscripts should be prepared according to our detailed Author Guidelines, which provide comprehensive instructions for formatting, structure, and style. Key requirements include:
- Title: Concise and descriptive (maximum 150 characters), accurately reflecting manuscript content
- Abstract: Structured abstract (Background, Methods, Results, Conclusions) of 250-300 words for research articles
- Keywords: 4-6 keywords for indexing, using MeSH terms where applicable
- Introduction: Clear statement of research objectives and significance to prostate cancer pathophysiology
- Methods: Sufficient detail for reproducibility; include statistical methods, sample sizes, and ethical approvals
- Results: Present findings logically with appropriate figures and tables; avoid interpretation in this section
- Discussion: Interpret results in context of existing literature; acknowledge limitations; suggest future research directions
- References: Vancouver style; minimum 25 references for research articles; recent publications (within 5 years) preferred
Figure and Table Requirements
- Figures: TIFF or EPS format, minimum 300 DPI resolution, RGB color mode
- Maximum figure size: 8.5 × 11 inches (portrait) or 11 × 8.5 inches (landscape)
- Tables: Editable format (Word or Excel), not embedded as images
- All figures and tables must be cited in text and include descriptive legends
- Avoid redundancy between figures and tables—present data in one format only
Ethical Considerations
- Human studies: IRB/Ethics committee approval required; informed consent documented
- Animal studies: IACUC approval required; adherence to ARRIVE guidelines mandatory
- Clinical trials: Registration in recognized trial registry (ClinicalTrials.gov, etc.) required
- Data sharing: Raw data should be made available upon reasonable request or deposited in public repositories
- Conflicts of interest: Full disclosure of financial relationships and competing interests required
Need Assistance?
Our editorial team is here to support you throughout the submission and peer review process. Whether you have questions about manuscript preparation, submission procedures, or publication timelines, we're ready to help.
Contact Editorial Support: [email protected]
